Chronic kidney disease is a long-term condition where the kidneys gradually lose function over time, leading to waste buildup in the body.

Common causes include diabetes, high blood pressure, glomerulonephritis, polycystic kidney disease, and recurrent kidney infections.

Symptoms may include fatigue, swelling in ankles and feet, nausea, shortness of breath, confusion, and decreased urine output.

Diagnosis is made through blood tests, urine tests, imaging studies, and sometimes a kidney biopsy to assess kidney function and damage.

Treatments include medications to manage symptoms, lifestyle changes, dialysis, and in severe cases, kidney transplantation.

It helps diagnose kidney diseases and assesses overall kidney function.

Typically, fasting is not necessary, but inform your healthcare provider about any medications or supplements.

It provides crucial information about kidney health, aiding in diagnosis, treatment, and monitoring of kidney diseases.

Results are usually available within a day, allowing for timely medical decisions based on kidney function assessment.

The target INR range for patients on warfarin therapy varies depending on their condition but is typically between 2.0 and 3.0.

Frequency of testing depends on individual patient needs, but initially, it may be done weekly or bi-weekly until stable, then less frequently thereafter.

Yes, the PT / INR Test can help diagnose various clotting disorders, including those related to liver disease or genetic clotting factor deficiencies.

Medications, dietary changes, liver function, and underlying health conditions can all influence PT / INR results.

Yes, the PT / INR Test is a safe and standard diagnostic procedure used worldwide to monitor blood clotting ability and adjust anticoagulant therapy.